These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36404444)

  • 1. Determinants of the progression to type 2 diabetes and regression to normoglycemia in people with pre-diabetes: A population-based cohort study over ten years.
    Kohansal K; Ahmadi N; Hadaegh F; Alizadeh Z; Azizi F; Habibi-Moeini AS; Khalili D
    Prim Care Diabetes; 2022 Dec; 16(6):797-803. PubMed ID: 36404444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
    Alizadeh Z; Baradaran HR; Kohansal K; Hadaegh F; Azizi F; Khalili D
    Front Endocrinol (Lausanne); 2022; 13():1041808. PubMed ID: 36277718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of body weight change and regression to normoglycemia in different phenotypes of pre-diabetes: Findings of a longitudinal cohort study.
    Bahadoran Z; Mirmiran P; Azizi F; Hosseinpanah F
    Clin Nutr ESPEN; 2024 Oct; 63():887-892. PubMed ID: 39214244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural History of Type 2 Diabetes in Indians: Time to Progression.
    Narayan KMV; Kondal D; Chang HH; Mohan D; Gujral UP; Anjana RM; Staimez LR; Patel SA; Ali MK; Prabhakaran D; Tandon N; Mohan V
    Diabetes Care; 2024 May; 47(5):858-863. PubMed ID: 38427346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.
    Moazzeni SS; Ghafelehbashi H; Hasheminia M; Parizadeh D; Ghanbarian A; Azizi F; Hadaegh F
    BMC Public Health; 2020 Oct; 20(1):1510. PubMed ID: 33023566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.
    Sevilla-González MDR; Merino J; Moreno-Macias H; Rojas-Martínez R; Gómez-Velasco DV; Manning AK
    Cardiovasc Diabetol; 2021 Feb; 20(1):56. PubMed ID: 33639941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between body mass index and reversion to normoglycemia from impaired fasting glucose among Chinese adults: a 5-year cohort study.
    Han Y; Hu H; Huang Z; Liu D
    Front Endocrinol (Lausanne); 2023; 14():1111791. PubMed ID: 37143738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year change in glycemic state and the future risk of incident hypertension among Iranian adults: Tehran Lipid and Glucose Study.
    Moazzeni SS; Dehghani S; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
    J Hum Hypertens; 2023 Oct; 37(10):944-949. PubMed ID: 36473941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of T2DM and the role of baseline glycaemic status as a determinant in a metropolitan population in northern Madrid (Spain).
    Iriarte-Campo V; de Burgos-Lunar C; Mostaza J; Lahoz C; Cárdenas-Valladolid J; Gómez-Campelo P; Taulero-Escalera B; San-Andrés-Rebollo FJ; Rodriguez-Artalejo F; Salinero-Fort MA;
    Diabetes Res Clin Pract; 2024 Mar; 209():111119. PubMed ID: 38307139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of adipose tissue dysfunction is associated with progression of pre-diabetes to type 2 diabetes: the Tehran Lipid and Glucose Study.
    Jalali M; Bahadoran Z; Mirmiran P; Azizi F; Hosseinpanah F
    BMC Public Health; 2024 Jan; 24(1):121. PubMed ID: 38191327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative associations of β-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: the MASALA study.
    Gujral UP; Narayan KM; Kahn SE; Kanaya AM
    J Diabetes Complications; 2014; 28(1):45-50. PubMed ID: 24211090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
    Gerstein HC; Coleman RL; Scott CAB; Xu S; Tuomilehto J; Rydén L; Holman RR;
    Diabetes Care; 2020 Sep; 43(9):2242-2247. PubMed ID: 32641379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with progression of different prediabetic status to Diabetes: A Community-based cohort study.
    Li N; Lu C; Ma Y; Wang X; Ling Y; Yin Y; Li S; Huang J; Yu L; Dong W; He H; Kang M; Ma L; Gu M; Zhao L; Huang Y; Liu F; Wang Y; Gai X; Jiang J; Peng Y; Ding X
    Diabetes Res Clin Pract; 2022 Feb; 184():109193. PubMed ID: 35032561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance.
    Cobb J; Eckhart A; Motsinger-Reif A; Carr B; Groop L; Ferrannini E
    Diabetes Care; 2016 Jun; 39(6):988-95. PubMed ID: 27208342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMI and All-Cause Mortality in Normoglycemia, Impaired Fasting Glucose, Newly Diagnosed Diabetes, and Prevalent Diabetes: A Cohort Study.
    Lee EY; Lee YH; Yi SW; Shin SA; Yi JJ
    Diabetes Care; 2017 Aug; 40(8):1026-1033. PubMed ID: 28400430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.